Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 Trading Update

5 May 2016 07:00

RNS Number : 3005X
Impellam Group plc
05 May 2016
 

Impellam Group plc

("Impellam" or the "Group")

 

Q1 Trading update

Impellam, a leading provider of managed services and specialist staffing expertise, today provides a trading update for the first quarter of the current financial year to 1st April 2016.

The Group performed strongly in Q1. The integration of the recently acquired Global Group and Bartech businesses is proceeding as planned and both businesses are performing well.

Overall net fee income increased by 27.2% compared with the same period in 2015 (7.5% organic growth), with a particularly strong performance in temporary staffing and managed services offsetting slight weakness in permanent placement fees. The latter represented only 11.2% of the net fee income in the quarter. The conversion of net fee income into earnings before interest and tax ("EBIT") was 22.6% in Q1, up from 16.4% in Q1 FY15, leaving the Group well placed to achieve a key strategic objective of conversion of net fee income into EBIT of 25% in FY17. Net debt at the end of Q1 was lower than management expectations and we continue to focus on cash generation to deliver significant deleveraging by the end of FY16.

Whilst the junior doctors' strikes in the UK have had an impact in Q1, our UK healthcare business has responded positively to the introduction of caps on doctors' and nurses' rates and this performance, combined with our growth internationally following the acquisition of Global Group, means that we are confident that our healthcare business will perform better than we originally expected in 2016.

We have recently implemented several new managed service wins including Airbus through Guidant and Daisy and Wonga through Lorien in the UK and are implementing a number of contracts in Australia through our Comensura business. The pipeline of opportunities across all our managed service businesses remains strong.

Overall, we remain on track to deliver results for the full year in line with management's expectations, with the strong Q1 performance underpinning the Board's confidence in the prospects for the Group.

For further information please contact:

Impellam Group plc

Julia Robertson, Chief Executive Tel: + 44 (0)1582 692658

Darren Mee, Group Finance Director

Cenkos Securities plc (NOMAD and Joint Corporate Broker to Impellam)

Nicholas Wells Tel: +44 (0)20 7397 8900

Mark Connelly

Investec Bank plc (Joint Corporate Broker to Impellam)

Chris Treneman Tel: +44 (0)207 597 4000

James Rudd

Josh Levy

Note to Editors:

Impellam Group plc, traded on AIM (Symbol: IPEL) is a leading provider of managed services and specialist staffing expertise and is primarily based in the UK and North America, with smaller operations in Asia Pacific, Ireland and mainland Europe. Impellam Group plc provides fulfilling jobs at all levels, including doctors, lawyers, accountants, nurses, teachers, scientists, receptionists, drivers, chefs, administrators, engineers, technology specialists, cleaners, security guards, and manufacturing and warehouse operatives. Impellam Group plc is the 2nd largest staffing business in the UK and 12th largest worldwide, employing over 3,100 people across 220 worldwide locations.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLZLLBQEFFBBD
Date   Source Headline
11th May 202310:47 amRNSForm 8.5 (EPT/RI)
11th May 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
10th May 202311:25 amRNSForm 8.3 - Impellam Group PLC
10th May 20239:56 amRNSForm 8.5 (EPT/RI)
10th May 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
9th May 202311:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
9th May 202310:54 amRNSForm 8.5 (EPT/RI)
5th May 20231:18 pmRNSForm 8.3 - Impellam Group PLC
5th May 20239:11 amRNSForm 8.5 (EPT/RI)
4th May 20232:30 pmRNSTransaction in Own Shares & Rule 2.9 Announcement
4th May 20238:21 amRNSForm 8.5 (EPT/RI)
3rd May 202311:23 amRNSForm 8.3 - Impellam Group Plc
3rd May 20238:08 amRNSForm 8.5 (EPT/RI)
2nd May 20231:30 pmRNSForm 8.3 - Impellam Group Plc
28th Apr 202312:12 pmRNSForm 8.3 - Impellam Group PLC
28th Apr 202311:05 amRNSForm 8.5 (EPT/RI)
28th Apr 20237:01 amRNSPublication of Annual Report
28th Apr 20237:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 30 DECEMBER 2022
26th Apr 20231:59 pmRNSForm 8.5 (EPT/RI)
26th Apr 202312:14 pmRNSForm 8.3 - Impellam Group PLC
25th Apr 20237:56 amRNSForm 8.5 (EPT/RI)
21st Apr 202310:29 amRNSForm 8.5 (EPT/RI) - amendment
21st Apr 20239:53 amRNSForm 8.3 - Impellam Group PLC
21st Apr 20237:41 amRNSForm 8.5 (EPT/RI)
21st Apr 20237:00 amRNSRule 2.9 Announcement
21st Apr 20237:00 amRNSTransaction in Own Shares
20th Apr 202311:28 amRNSForm 8.5 (EPT/RI)
20th Apr 20239:00 amRNSRule 2.9 Announcement
20th Apr 20239:00 amRNSTransaction in Own Shares
19th Apr 20239:21 amRNSForm 8.3 - Impellam Group PLC
19th Apr 20237:02 amRNSForm 8.5 (EPT/RI)
17th Apr 20231:44 pmRNSForm 8.3 - Impellam Group Plc
14th Apr 202312:29 pmRNSForm 8.3 - Impellam Group PLC
13th Apr 202312:12 pmRNSForm 8.3 - Impellam Group PLC
11th Apr 202311:45 amRNSForm 8.5 (EPT/RI)
6th Apr 20234:45 pmRNSRule 2.9 Announcement
6th Apr 20234:45 pmRNSTransaction in Own Shares
4th Apr 202311:09 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
4th Apr 20239:00 amRNSRule 2.9 Announcement
4th Apr 20239:00 amRNSTransaction in Own Shares
3rd Apr 202310:59 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
3rd Apr 20239:00 amRNSRule 2.9 Announcement
3rd Apr 20239:00 amRNSTransaction in Own Shares
31st Mar 202311:13 amRNSForm 8.5 (EPT/RI)
31st Mar 20237:00 amRNSRule 2.9 Announcement
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 202310:34 amRNSForm 8.5 (EPT/RI)
30th Mar 20239:30 amRNSRule 2.9 Announcement
30th Mar 20237:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 30 DEC 2022
30th Mar 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.